Cell Therapies

Speaker - Funded(s)

• 

  Matt Gafencu, BS EE (he/him/his)

  Principal Customer Solutions Manager
  Amazon Web Services (AWS), United States
• 

  Laura Herbst

  Research Fellow
  Fraunhofer-Institute for Production Technology, Germany

Speaker - Not Funded(s)

• SC

  Scott Cribbes, PhD

  Senior Manager
  Nexcelom from PerkinElmer, United Kingdom
• 

  David Rodgers, PhD (he/him/his)

  Senior Director Cell Therapy
  Shoreline Biosciences, United States

Presentations:

• 10:30 – 11:00 CET

  Changing Lanes For Cell Therapy
  

  David T. Rodgers, PhD (he/him/his) – Shoreline Biosciences
• 11:00 – 11:30 CET

  Artificial Intelligence and Automation enabling rapid, widely available autologous CAR-T cell therapy
  

  Laura Herbst – Fraunhofer-Institute for Production Technology
• 11:30 – 12:00 CET

  Best practices of 2D and 3D CAR T cytotoxicity assay using high throughput plate based image cytometry
  

  Scott Cribbes, PhD – Nexcelom from PerkinElmer
• 12:00 – 12:30 CET

  Accelerating Precision Medicine - Turning data into insights using AI and automation
  

  Matt Gafencu, BS EE (he/him/his) – Amazon Web Services (AWS)